Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Moriwaki

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical Calcium|September 16, 2017
[Cost-effectiveness of implementing Osteoporosis Liaison Service program.]Kensuke Moriwaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Cost-effectiveness considerations in the treatment of osteoporosis]Kensuke Moriwaki
Clinical Calcium|April 29, 2014
[Epidemiology of bone and joint disease - the present and future - . Health economics of osteoporosis and osteoporotic fractures]Kensuke Moriwaki
Infection Control and Hospital Epidemiology|May 27, 2016
Cost-Effectiveness Analysis of Safety-Engineered DevicesHaruhisa Fukuda, Kensuke Moriwaki
BMC Endocrine Disorders|May 23, 2021
Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratificationSachiko Ohde, Kensuke Moriwaki, Osamu Takahashi
Clinical Drug Investigation|June 8, 2022
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in JapanXiuting Mo, Kensuke Moriwaki, Kosuke Morimoto, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in JapanHirotaka Komaba, Kensuke Moriwaki, Isao Kamae, et al.
Journal of Gastroenterology|September 19, 2023
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in JapanKosuke Morimoto, Kensuke Moriwaki, Kojiro Shimozuma, et al.
Value in Health Regional Issues|December 11, 2025
Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in JapanSeiya Taniguchi, Kensuke Moriwaki, Kosuke Morimoto, et al.
Plos One|August 14, 2020
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinomaHaruhisa Fukuda, Daisuke Sato, Kensuke Moriwaki, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical Calcium|September 16, 2017
[Cost-effectiveness of implementing Osteoporosis Liaison Service program.]Kensuke Moriwaki
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Cost-effectiveness considerations in the treatment of osteoporosis]Kensuke Moriwaki
Clinical Calcium|April 29, 2014
[Epidemiology of bone and joint disease - the present and future - . Health economics of osteoporosis and osteoporotic fractures]Kensuke Moriwaki
Infection Control and Hospital Epidemiology|May 27, 2016
Cost-Effectiveness Analysis of Safety-Engineered DevicesHaruhisa Fukuda, Kensuke Moriwaki
BMC Endocrine Disorders|May 23, 2021
Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratificationSachiko Ohde, Kensuke Moriwaki, Osamu Takahashi
Clinical Drug Investigation|June 8, 2022
Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in JapanXiuting Mo, Kensuke Moriwaki, Kosuke Morimoto, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 22, 2009
Towards cost-effective strategies for treatment of chronic kidney disease-mineral and bone disorder in JapanHirotaka Komaba, Kensuke Moriwaki, Isao Kamae, et al.
Journal of Gastroenterology|September 19, 2023
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in JapanKosuke Morimoto, Kensuke Moriwaki, Kojiro Shimozuma, et al.
Value in Health Regional Issues|December 11, 2025
Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in JapanSeiya Taniguchi, Kensuke Moriwaki, Kosuke Morimoto, et al.
Plos One|August 14, 2020
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinomaHaruhisa Fukuda, Daisuke Sato, Kensuke Moriwaki, et al.
Pageof 4